Inflammatory breast cancer: Current concepts in local management

Breast Disease

Volumn 22, Issue , 2005, Pages 75-83

  Bristol, Ian J ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DOXORUBICIN;

ADVANCED CANCER; ASPIRATION BIOPSY; BRACHIAL PLEXUS INJURY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DESQUAMATION; DISEASE FREE SURVIVAL; DOSE CALCULATION; ERYTHEMA; EVIDENCE BASED MEDICINE; HUMAN; INFLAMMATORY BREAST CANCER; INOPERABLE CANCER; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPHEDEMA; MAMMOGRAPHY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION PNEUMONIA; RECURRENCE RISK; REVIEW; RIB FRACTURE; RISK BENEFIT ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; AGED; BREAST TUMOR; CANCER STAGING; CONTROLLED CLINICAL TRIAL; FEMALE; MEGAVOLTAGE RADIOTHERAPY; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEGMENTAL MASTECTOMY;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33745616150     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/bd-2006-22109     Document Type: Review

References (33)

1. F. Bozzetti, R. Saccozzi, M. De Lena and B. Salvadori, Inflammatory cancer of the breast: Analysis of 114 cases, J Surg Oncol 18 (1981), 355-361.
2. C.D. Haagenson, Diseases ofthe Breast, Philadelphia: WB Saunders Company; 1971, 576-585.
3. P.A. Wingo, P.M. Jamison, J.L. Young and P. Gargiullo, Population-based statistics for women diagnosed with inflammatory breast cancer (United States), Cancer Causes Control 15 (2004), 321-328.
4. Z. Liao, E.A. Strom, A.U. Buzdar et al., Locoregional irradiation for inflammatory breast cancer: Effectiveness of dose escalation in decreasing recurrence, Int J Radiat Oncol Biol Phys 47 (2000), 1191-200.
5. S.L. Liauw, R.K. Benda, C.G. Morris and N.P. Mendenhall, Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease, Cancer 100 (2004), 920-928.
6. M. Panades, I.A. Olivotto, C.H. Speers et al., Evolving treatment strategies for inflammatory breast cancer: A population-based survival analysis, J Clin Oncol 23 (2005), 1941-1950.
7. R.Y. Fleming, L. Asmar, A.U. Buzdar et al., Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma, Ann Surg Oncol 4 (1997), 452-461.
8. A. Hasbini, C. Le Pechoux, B. Roche et al., [Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer], Cancer Radiother 4 (2000), 265-273.
9. F. Thomas, R. Arriagada, M. Spielmann et al., Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy, Cancer 76 (1995), 2286-2290.
10. J.L. Barker, A.J. Nelson and E.D. Montague, Inflammatory carcinoma of the breast, Radiology 121 (1976), 173-176.
11. R. Zucali, C. Uslenghi, R. Kenda and G. Bonadonna, Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy, Cancer 37 (1976), 1422-1431.
12. J.N. Fields, C.A. Perez, R.R. Kuske et al., Inflammatory carcinoma of the breast: Treatment results on 107 patients, Int J Radiat Oncol Biol Phys 17 (1989), 249-255.
13. A.N. Krutchik, A.U. Buzdar, G.R. Blumenschein et al., Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma, J Surg Oncol 11 (1979), 325-332.
14. J.L. Barker, E.D. Montague and L.J. Peters, Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy, Cancer 45 (1980), 625-629.
15. P.H. Levine, S.C. Steinhorn, L.G. Ries and J.L. Aron, Inflammatory breast cancer: The experience of the surveillance, epidemiology, and end results (SEER) program, J Natl Cancer Inst 74 (1985), 291-297.
16. H.D. Thames, Jr., L.J. Peters, H.R. Withers and G.H. Fletcher, Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day, Int J Radiat Oncol Biol Phys 9 1983), 127-138.
17. W.W. Thoms, Jr., M.D. McNeese, G.H. Fletcher et al., Multimodal treatment for inflammatory breast cancer, Int J Radiat Oncol Biol Phys 17 (1989), 739-745.
18. F. Maloisel, P. Dufour, J.P. Bergerat et al., Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast, Cancer 65 (1990), 851-855.
19. E. Baldini, G. Gardin, G. Evagelista et al., Long-term results of combined-modality therapy for inflammatory breast carcinoma, Clin Breast Cancer 5 (2004), 358-363.
20. E.E. Harris, D. Schultz, H. Bertsch et al., Ten-year outcome after combined modality therapy for inflammatory breast cancer, Int J Radiat Oncol Biol Phys 55 (2003), 1200-1208.
21. A.M. Chu, O. Cope, R. Russo et al., Treatment of early stage breast cancer by limited surgery and radical irradiation, Int J Radiat Oncol Biol Phys 6 (1980), 25-30.
22. T.M. Pisansky, D.J. Schaid, C.L. Loprinzi et al., Inflammatory breast cancer: Integration of irradiation, surgery, and chemotherapy, Am J Clin Oncol 15 (1992), 376-387.
23. M.T. Ballo, E.A. Strom, H. Prost et al., Local-regional control of recurrent breast carcinoma after mastectomy: Does hyperfractionated accelerated radiotherapy improve local control? Int J Radiat Oncol Biol Phys 44 (1999), 105-112.
24. D.W. Arthur, R.K. Schmidt-Ullrich, R.B. Friedman et al., Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation, Int J Radiat Oncol Biol Phys 44 (1999), 289-296.
25. R.H. De Boer, W.H. Allum, S.R. Ebbs et al., Multimodality therapy in inflammatory breast cancer: Is there a place for surgery? Ann Oncol 11 (2000), 1147-1153.
26. C.A. Perez, J.N. Fields, P.M. Fracasso et al., Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma, Cancer 74 (1994), 466-476.
27. J.A. Low, A.W. Berman, S.M. Steinberg et al., Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy, J Clin Oncol 22 (2004), 4067-4074.
28. B. Brun, Y. Otmezguine, F. Feuilhade et al., Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation, Cancer 61 (1988), 1096-1103.
29. B. Chevallier, B. Asselain, A. Kunlin et al., Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis, Cancer 60 (1987), 897-902.
30. K.J. Pierce, M. Lippman, N. Ben-Baruch et al., The effect of systemic therapy on local-regional control in locally advanced breast cancer, Int J Radiat Oncol Biol Phys 23 (1992), 949-960.
31. S.M. Swain and M.E. Lippman, Treatment of patients with inflammatory breast cancer, Important Adv Oncol (1989), 129-150.
32. S.M. Swain, R.A. Sorace, C.S. Bagley et al., Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer, Cancer Res 47 (1987), 3889-3894.
33. N.T. Ueno, A.U. Buzdar, S.E. Singletary et al., Combined-modality treatment of inflammatory breast carcinoma: Twenty years of experience at M. D. Anderson Cancer Center, Cancer Chemother Pharmacol 40 (1997), 321-329.